Implied Volatility Surging for ICU Medical Stock Options
Investors need to pay close attention to ICUI stock based on the movements in the options market lately.
ICUI - ICU Medical, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$163.50
DETAILS
HIGH:
$164.00
LOW:
$163.00
MEDIAN:
$163.50
CONSENSUS:
$163.50
UPSIDE:
22.65%
Stock News
ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.72 per share a year ago.
ICU Medical Announces First Quarter 2026 Results
SAN CLEMENTE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2026.
Madison Small Cap Fund Q1 2026 Portfolio Activity
ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
ICU Medical (ICUI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ICU Medical Inc (ICUI) Stock Down 4.6% -- Now Undervalued? GF Score: 86/100
On April 29, 2026, ICU Medical Inc (ICUI) shares fell 4.6% today, bringing the current price to $115.45. This decline is part of a larger trend, with the stock
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
SAN CLEMENTE, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2026 earnings release and conference call.
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
NEW YORK, April 16, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ICU Medical, Inc. (NASDAQ: ICUI) on behalf of the company's shareholders. The investigation seeks to determine whether ICU Medical's directors breached their fiduciary duties in connection with recent corporate actions.
ICU Medical Calls Itself a “Pure-Play Infusion” Leader, Details Pricing, Pumps and Buyback Plans
ICU Medical (NASDAQ: ICUI) executives highlighted the company's evolution into what CEO Vivek Jain described as "the world's only pure-play infusion company" during a fireside chat at the 25th Annual Needham Healthcare Conference, while also addressing pricing dynamics, product roadmaps, macro pressures, and capital allocation priorities. Company evolution and investment positioning Jain said ICU Medical has
ICU Medical Moving Toward A Cleaner Margin Leverage And Capital Return Story
ICU Medical is positioned for margin expansion as Smiths Medical integration and remediation costs subside, with upcoming product launches supporting growth. ICUI is gaining share in infusion pumps and consumables, leveraging product differentiation and rebounding from past compliance issues. Management targets net debt/EBITDA below 2.0x, opening the door for increased capital returns via buybacks or dividends within a couple of years.
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI)
Sanara MedTech (NASDAQ: SMTI - Get Free Report) and ICU Medical (NASDAQ: ICUI - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, institutional ownership and valuation. Insider and Institutional Ownership 8.1% of Sanara MedTech
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
NEW YORK, March 25, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating ICU Medical, Inc. (NASDAQ: ICUI) on behalf of the company's shareholders. The investigation seeks to determine whether ICU Medical's directors breached their fiduciary duties in connection with recent corporate actions.
Victory Capital Management Inc. Purchases 53,619 Shares of ICU Medical, Inc. $ICUI
Victory Capital Management Inc. increased its position in ICU Medical, Inc. (NASDAQ: ICUI) by 33.7% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 212,520 shares of the medical instruments supplier's stock after purchasing an additional 53,619 shares during
ICU Medical to Participate in Upcoming Investor Conferences
SAN CLEMENTE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences:
ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript
ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript
ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $2.11 per share a year ago.
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
SAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.
Bryce Point Capital LLC Takes $586,000 Position in ICU Medical, Inc. $ICUI
Bryce Point Capital LLC bought a new position in ICU Medical, Inc. (NASDAQ: ICUI) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,886 shares of the medical instruments supplier's stock, valued at approximately $586,000. A number of other
Price Targets
ICU Medical price target lowered to $164 from $180 at KeyBanc
$164.00
(was $124.82)
KeyBanc
ICU Medical price target lowered to $163 from $178 at Piper Sandler
$163.00
(was $126.04)
Jason Bednar
·
Piper Sandler
ICU Medical price target raised to $178 from $172 at Piper Sandler
$178.00
(was $149.74)
Piper Sandler
ICU Medical price target raised to $180 from $175 at KeyBanc
$180.00
(was $149.74)
Brett Fishbin
·
KeyBanc
ICU Medical price target lowered to $173 from $191 at KeyBanc
$173.00
(was $117.34)
Brett Fishbin
·
KeyBanc
ICU Medical price target raised to $153 from $145 at Piper Sandler
$153.00
(was $132.74)
Jason Bednar
·
Piper Sandler
Piper Sandler bullish on ICU Medical, initiates with an Overweight
$145.00
(was $119.32)
Jason Bednar
·
Piper Sandler
ICU Medical upgraded to Strong Buy from Outperform at Raymond James
$97.00
(was $138.99)
Strong Buy
·
Raymond James
ICU Medical price target raised to $198 from $147 at KeyBanc
$198.00
(was $180.30)
Brett Fishbin
·
KeyBanc
Jefferies Starts ICU Medical (ICUI) at Hold
$183.00
(was $178.72)
Michael Toomey
·
Jefferies
Raymond James Upgrades ICU Medical (ICUI) to Outperform
$135.00
(was $117.44)
Jayson Bedford
·
Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $190
$190.00
(was $188.10)
Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $208
$208.00
(was $179.63)
Raymond James
Raymond James Maintains Outperform on ICU Medical, Lowers Price Target to $235
$235.00
(was $201.17)
Raymond James